Patients with Gaucher disease should be regularly monitored with blood tests, measurement of the viscera (spleen and liver), and skeleton scans.1 The monitoring interval, which is usually every 6-24 months, depends on the recommendations of the healthcare provider, the patient's disease, and/or treatment.1
Blood tests are often used to monitor disease progression and measure a patient’s:1-2
Additionally, the serum levels of several biological markers indicate disease severity and progression:1-3
Visceral volumes can be assessed with:
Skeletal scans are used to detect bone marrow infiltration and bone disease and can be assessed with: